Vol. 29 (4) 2022
Antibodies against a mutated citrullinated vimentin in patients with rheumatoid arthritis The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 184–194. www.Ejimmunology.org https://doi.org/10.55133/eji.290418 Dalia A. Nigm1, Hanan H. Abdel-Lateef1,...
Vol. 29 (4) 2022
Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 174–183. www.Ejimmunology.org https://doi.org/10.55133/eji.290417 Mohamed H. Abd Allah1,...
Vol. 29 (4) 2022
sVCAM-1, and TGFβ1 in chronic phase, chronic myeloid leukemia patients treated with tyrosine kinase inhibitors The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 163–173. www.Ejimmunology.org https://doi.org/10.55133/eji.290416 Muhamad R. Abdel...
Vol. 29 (4) 2022
Serum IgG4 level for malignancy prediction in indeterminate thyroid nodules among patients with or without autoimmune thyroid disease The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 156–162. www.Ejimmunology.org...
Vol. 29 (4) 2022
Serum interleukin-33 (IL-33) in children with active systemic lupus erythematosus: A cross-sectional study The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 148–155. www.Ejimmunology.org https://doi.org/10.55133/eji.290414 Rana I. Abd-Elazeem1,...
Vol. 29 (4) 2022
Detection of ERG11 gene in fluconazole resistant urinary candida isolates The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 134–147. www.Ejimmunology.org https://doi.org/10.55133/eji.290413 Manal El Said1,2, Hala Badawi1, Doaa Gamal3, Dalia...
